Skip to main content
SpringerLink
Log in

Immunologische Aspekte maligner Melanome

  • Chapter
Malignes Melanom

Zusammenfassung

Klinische und histologische Beobachtungen führten zu der Vorstellung, daß immunologische Vorgänge bei der Melanomerkrankung eine wichtige Rolle spielen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abo T, Balch CM (1981) A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 127:1024–1029

    PubMed  CAS  Google Scholar 

  2. Albino AP, Lloyd KO, Houghton AN, Oettgen HF, Old LJ (1981) Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. J Exp Med 154:1764–1778

    PubMed  CAS  Google Scholar 

  3. Auerbach R (1981) Angiogenesis-inducing factors: a review. In: Pick E, Landy M (Hrsg) Lymphokines, Bd 4. Academic Press, New York, pp 61–88

    Google Scholar 

  4. Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA (1978) A multifactorial Analysis of Melanoma: Prognostic histopathological features comparing Clark’s and Breslow’s staging methods. Ann Surg 188:732–742

    PubMed  CAS  Google Scholar 

  5. Bernard D, Maurizis JC, Ruse F, Chassagne J, Chollet P, Sauvezie B, De Latour M, Plagne R (1984) Presence of HLA-D/DR antigens on the membrane of breast tumour cells. Clin Exp Immunol 56:215–221

    PubMed  CAS  Google Scholar 

  6. Bhan AK, Mihm C, Dvorak HF (1982) T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies. J Immunol 129:1578–1583

    PubMed  CAS  Google Scholar 

  7. Bhan AK, DesMarais CL (1983) Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. JNCI 71:507–516

    PubMed  CAS  Google Scholar 

  8. Breard J, Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1980) A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol 124:1943–1948

    PubMed  CAS  Google Scholar 

  9. Brodt P, Lala PK (1983) Changes in the host lymphocyte subsets during chemical carcinogenesis. Cancer Res 143:4315–4322

    Google Scholar 

  10. Bröcker EB, Kolde G, Steinhausen D, Peters A, Macher E (1984) The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas. J Cancer Res Clin Oncol 107:48–52

    PubMed  Google Scholar 

  11. Bröcker EB, Suter L, Sorg C (1984) HLA-DR antigen expression in primary melanomas of the skin. J Invest Dermatol 82:244–247

    PubMed  Google Scholar 

  12. Bröcker EB, Brüggen J, Suter L, Ruiter DJ, Macher E, Sorg C (1984) Prognostic significance of melanoma-associated antigens in primary and metastatic melanomas. In: McDonald DM (ed) Immunodermatology, pp 71–74

    Google Scholar 

  13. Brown JP, Wright PW, Hart CE, Woodbury G, Hellstrom KE, Hellstrom I (1980) Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies. J Biol Chem 255:4980–4983

    PubMed  CAS  Google Scholar 

  14. Brüggen J, Macher E, Sorg C (1981) Expression of surface antigens and its relation to parameters of malignancy in human malignant melanoma. Cancer Immunol Immunother 10:121–127

    Google Scholar 

  15. Brüggen J, Sorg C (1983) Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies. Cancer Immunol Immunother 15:200–205

    PubMed  Google Scholar 

  16. Brüggen J, Redmann K, Sorg C (1983) Changes of biochemical and antigenic properties in human melanoma cells after treatment with biological response modifiers. J Cancer Res Clin Oncol 105:A 38

    Google Scholar 

  17. Brunner KT, MacDonald HR, Cerottini JC (1981) Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcome virus-induced tumors. J Exp Med 154:362–373

    PubMed  CAS  Google Scholar 

  18. Buessow SC, Paul RD, Miller AM, Lopez DM (1984) Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocarcinoma. I. Characterization of an in situ lymphocyte suppressor population by surface markers and functional reactivity. Int J Cancer 33:79–85

    PubMed  CAS  Google Scholar 

  19. Bumol TF, Reisfeld RA (1982) Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc Natl Acad Sei USA 79:1245–1249

    CAS  Google Scholar 

  20. Carrel S, Accolla RS, Carmagnola AL, Mach JP (1980) Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res 40:2523–2528

    PubMed  CAS  Google Scholar 

  21. Carrel S, de Tribolet N, Mach JP (1982) Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. Acta Neuropathol (Berl) 57:158–164

    CAS  Google Scholar 

  22. Casellas P, Brown JP, Gros O, Gros P, Hellström I, Jansen FK, Poncelet P, Roncucci R, Vidal H, Hellström KE (1982) Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p 97. Int J Cancer 30:437–443

    PubMed  CAS  Google Scholar 

  23. Ceuppens J, Goodwin JS (1981) Prostaglandins and the immune response to cancer (review). Anticancer Research 1:71–78

    PubMed  CAS  Google Scholar 

  24. Czarnetzki BM, Denter M, Bröcker EB, Rümke P, Krieg V, Vakilzadeh F, Macher E (1984) Clinical features of superficial spreading melanomas with zones of regression. J Cancer Res Clin Oncol 107:225–228

    PubMed  CAS  Google Scholar 

  25. Daar AS, Fuggle SV, Ting A, Fabre JW (1982) Anamolous expression of HLA-DR antigens on human colorectal cancer cells. J Immunol 129:447–449

    PubMed  CAS  Google Scholar 

  26. Diala ES, Cheah MSC, Rowitch D, Hoffman RM (1983) Extent of DNA methylation in human tumor cells. JNCI 71:755–764

    PubMed  CAS  Google Scholar 

  27. Dippold WG, Lloyd KO, Li LTC, Keda H, Oettgen HF, Old LJ (1980) Cell surface antigens of human malignant melanoma: Definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sei USA 77:6114–6118

    CAS  Google Scholar 

  28. Dvorak AM, Mihm MC Jr, Osage JE, Dvorak HF (1980) Melanoma. An ultrastructural study of the host inflammatory and vascular responses. J Invest Dermatol 75:388–393

    PubMed  CAS  Google Scholar 

  29. Evans RL, Faldetta TJ, Humphreys RE, Pratt DM, Yunis EJ, Schlossman SF (1978) Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia- like antigens. J Exp Med 148:1440–1448

    PubMed  CAS  Google Scholar 

  30. Evans R (1979) Host cells in transplanted murine tumors and their possible relevance to tumor growth. J Reticuloendothel Soc 26:427–437

    PubMed  CAS  Google Scholar 

  31. Flodgren P, Borgström S, Jönsson PE, Lindström C, Sjögren HO (1983) Metastatic malignant melanoma: Regression induced by combined treatment with interon (HuIFNα(Le)) and Cimetidine. Int J Cancer 32:657–665

    PubMed  CAS  Google Scholar 

  32. Garrigues HJ, Tilgen W, Hellström I, Franke W, Hellström KE (1982) Detection of a human melanoma-associated antigen, p97 in histological sections of primary human melanomas. Int J Cancer 29:511–515

    PubMed  CAS  Google Scholar 

  33. Gatenby PA, Basten A, Creswick P (1981) “Sneaking through”: A T-cell-dependent phenomenon. Br J Cancer 44:753–756

    PubMed  CAS  Google Scholar 

  34. Goodwin JS, Bankhurst AD, Messner RP (1977) Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med 146:1719–1734

    PubMed  CAS  Google Scholar 

  35. Goodwin JS, Husby G, Williams Jr RC (1980) Prostaglandin E and Cancer Growth. Cancer Immunol Immunother 8:3–7

    CAS  Google Scholar 

  36. Gromet MA, Epstein WL, Blois MS (1978) The regressing thin malignant melanoma. A distinctive lesion with metastatic potential. Cancer 42:2282–2292

    PubMed  CAS  Google Scholar 

  37. Hacene K, Le Doussal V, Brunet M, Lemoine F, Guerin P, Hebert H (1983) Prognostic index for clinical stage I cutaneous malignant melanoma. Cancer Res 43:2991–2996

    PubMed  CAS  Google Scholar 

  38. Hageman Ph, Vennegoor C, van der Valk M, Landegert J, Jonker A, van der Mispel L (1982) Reactions of monoclonal antibodies against human melanoma with different tissues and cell lines. In: Peeters H (ed) Protides of the Biological Fluids. 29:889–892. Pergamon Press, Oxford

    Google Scholar 

  39. Hanafusa T, Chiovato L, Doniach D, Pujol-Borrell R, Russel RCG, Bottazzo GF (1983) Aberrant expression of HLA-DR antigen on thyrocytes in graves’ disease: relevance for autoimmunity. Lancet II: 1111–1115

    Google Scholar 

  40. Hansen MG, McCarten AB (1974) Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck. Am J Pathol 128:557–561

    CAS  Google Scholar 

  41. Hellström I, Garrigues HJ, Cabasco L, Mosely GH, Brown JP, Hellström KE (1983) Studies of a high molecular weight human melanoma-associated antigen. J Immunol 130:1467–1472

    PubMed  Google Scholar 

  42. Hellström KE, Hellström I, Brown JP, Larson SM, Nepon GT, Carrasquillo JA (1984) Three human melanoma-associated antigens and their possible clinical application. Contr Oncol 19:121–131

    Google Scholar 

  43. Herberman RB (ed) (1982) NK Cells and other Natural Effector Cells. Academic Press, New York

    Google Scholar 

  44. Hibbs JB (1973) Macrophage nonimmunologic recognition: Target cell functors related to contact inhibition. Science 180:868–870

    PubMed  Google Scholar 

  45. Hirschberg H, Bergh OJ, Thorsby E (1980) Antigen-presenting properties of human vascular endothelial cells. J Exp Med 152:249–255

    Google Scholar 

  46. Hirschberg H, Braathen LR, Thorsby E (1982) Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: The role of HLA-DR. Immunol Rev 66:57–77

    PubMed  CAS  Google Scholar 

  47. Houghton AN, Eisinger M, Albino AP, Cairncross JG, Old LJ (1982) Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med 156:17550–1766

    Google Scholar 

  48. Imai I, Ng AK, Glassy MC, Ferrone S (1981) Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: Relationship to susceptibility to immune lysis mediated by monoclonal antibodies. J Immunol 127:505

    PubMed  CAS  Google Scholar 

  49. Kabawat SE, Bast RC Jr, Welch WR, Knapp RC, Bhan AK (1983) Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms. Int J Cancer 32:547–554

    PubMed  CAS  Google Scholar 

  50. Karavodin LM, Giuliano AE, Golub SH (1981) T lymphocyte subsets in patients with malignant melanoma. Cancer Immunol Immunother 11:251–254

    Google Scholar 

  51. Kaszubowski PW, Husby G, Tung KSK, Williams Jr RC (1980) T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients. Cancer Res 40:4648–4657

    PubMed  CAS  Google Scholar 

  52. Klareskog L, Forsum U, Peterson PA (1980) Hormonal regulation of the expression of la antigens on mammary gland epithelium. Eur J Immunol 10:958–963

    PubMed  CAS  Google Scholar 

  53. Klimetzek V, Sorg C (1979) The production of fibrinolysis inhibitors as a parameter of the activation state in murine macrophages. Eur J Immunol 9:613–619

    PubMed  CAS  Google Scholar 

  54. Knuth A, Dippold W, Meyer zum Büschenfelde K-H (1984) Target level blocking of T-cell cytotoxicity for human malignant melanoma by monoclonal antibodies. Cell Immunol 83:398–03

    PubMed  CAS  Google Scholar 

  55. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497

    PubMed  Google Scholar 

  56. Kokoschka EM, Niebauer G (1976) Zur histologischen Prognosestellung beim primären Melanoma. Wien Klin Wochenschr 88:685–689

    CAS  Google Scholar 

  57. Kokoschka EM, Luger TA, Köck A, Wirth U, Vetterlein M, Micksche M (1983) Stimulierbare Produktion eines Interleukin 1-assoziierten „Thymozyten-aktivierenden Faktors” durch Melanomzellen. Vortrag ADF, Kiel 13. 11. 1983

    Google Scholar 

  58. Koprowski H, Steplewski Z, Herlyn D, Herlyn M (1978) Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA 75:3405–3409

    PubMed  CAS  Google Scholar 

  59. ornstein MJ, Brooks JSJ, Elder DE (1983) Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi. Cancer Res 43:2749–2753

    PubMed  CAS  Google Scholar 

  60. Larsen TE, Grude TH (1978) A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumourassociated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invascion, ulceration, tumour type and prognosis. Acta Pathol Microbiol Scand Immunol [A] 86:523–530

    Google Scholar 

  61. Larson SM, Carrasquillo JA, Krohn KA, Brown JP, McGuffin RW, Ferens JM, Graham LD, Beaumier PL, Hellström KE, Hellström I (1983) Localization of 131I-labelled p97- specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest 72:2101–2114

    PubMed  CAS  Google Scholar 

  62. Ledbetter JA, Evans RL, Lipinski M, Cunningham-Rundles C, Good RA, Herzenberg LA (1981) Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med 153:310–323

    PubMed  CAS  Google Scholar 

  63. Macher E, Czarnetzki BM, Vakilzadeh F (1983) Malignes Melanom-Klinik. In: Luger A, Gschnait F (Hrsg) Dermatologische Onkologie. Wien München Baltimore S 145–177

    Google Scholar 

  64. MacKie RM, Campbell I, Turbitt ML (1984) Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol 37:367–372

    PubMed  CAS  Google Scholar 

  65. McGovern VJ, Shaw HM, Milton GW, Farago GA (1982) Lymphocytic infiltration and survival in malignant melanoma. In: Ackerman AB (ed) Pathology of Malignant Melanoma. Masson, New York, pp 341–344

    Google Scholar 

  66. Maclllmurray MB, Embleton MJ, Reeves WG, Langsman MJS, Deane M (1977) Controlled trial of active immunotherapy in management of stage IIB malignant melanoma. Br Med J 1977:540

    Google Scholar 

  67. McLean DI, Lew RA, Sober AJ, Mihm MC Jr, Fitzpatrick TB (1979) On the prognostic importance of white depressed areas in the primary lesion of superficial spreading Melanoma. Cancer 43:157–161

    PubMed  CAS  Google Scholar 

  68. McMichael AJ, Ting A, Zweerink HJ, Askonas BA (1977) HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature 270:524–526

    PubMed  CAS  Google Scholar 

  69. Mengersen R, Schick R, Kölsch E (1975) Correlation of “sneaking through” of tumor cells with specific immunological impairment of the host. Eur J Immunol 5:532–537

    PubMed  CAS  Google Scholar 

  70. Moore M, Vose BM (1981) Extravascular natural cytotoxicity in man: Anti-K562 activity of lymph-node and tumour-infiltrating lymphocytes. Int J Cancer 27:265–272

    PubMed  CAS  Google Scholar 

  71. Natali PG, Aguzzi A, Veglia F, Imai K, Burlage RS, Giacomini P, Ferrone S (1983) The impact of monoclonal antibodies on the study of human malignant melanoma. J Cutan Pathol 10:514–528

    CAS  Google Scholar 

  72. Natali PG, Cavaliere R, Bigotti A, Nicotra MR, Russo C, Ng AK, Giacomini P, Ferrone S (1983) Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions. J Immunol 130:1462–1466

    PubMed  CAS  Google Scholar 

  73. Peter HH, Knoop F, Kalden JR (1976) Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control persons. Z Immun Forsch 151:263–281

    CAS  Google Scholar 

  74. Peter HH (1983) The immunology of malignant melanoma and possible immunotherapeutic approaches. In: Mackie R (ed) Pigment Cell, Vol. 6, Karger, Basel, p 65–92

    Google Scholar 

  75. Polverini PJ, Cotran RS, Gimbrone Jr MA, Unanue ER (1977) Activated macrophages induce vascular proliferation. Nature 269:804–806

    PubMed  CAS  Google Scholar 

  76. Poppema S, Bhan AK, Reinherz EL, McCluskey RT, Schlossman SF (1981) Distribution of T cell subsets in human lymph nodes. J Exp Med 153:30–41

    PubMed  CAS  Google Scholar 

  77. Poppema S, Bröcker EB, De Leij L, Terbrack D, Visscher T, Ter Haar A, Macher E, Thé TH, Sorg C (1983) In situ analysis of the mononuclear cell infíltrate in primary malignant melanoma of the skin. Clin Exp Immunol 51:77–82

    PubMed  CAS  Google Scholar 

  78. Poulter LW (1983) Antigen presenting cells in situ: their identification and involvement in immunopathology. Clin Exp Immunol 53:513–520

    PubMed  CAS  Google Scholar 

  79. Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oettgen HF, Old LJ (1982) GD3, a prominent ganglioside of human melanoma. Detection and characterization by mouse monoclonal antibody. J Exp Med 155:1133–1147

    PubMed  CAS  Google Scholar 

  80. Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1979) A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol 123:1312–1317

    PubMed  CAS  Google Scholar 

  81. Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1979) Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol 123:2894–2896

    PubMed  CAS  Google Scholar 

  82. Reinherz EL, Kung PC, Pesando JM, Ritz J, Goldstein G, Schlossman SF (1979) Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med 150:1472–1482

    PubMed  CAS  Google Scholar 

  83. Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1980) A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol 124:1301 -1307

    PubMed  CAS  Google Scholar 

  84. Rowe DJ, Beverley PCL (1984) Characterization of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens. Br J Cancer 49:149–159

    PubMed  CAS  Google Scholar 

  85. Ruiter DJ, Bhan AK, Harrist TJ, Sober AJ, Mihm MC Jr (1982) Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J Immunol 129:2808–2815

    PubMed  CAS  Google Scholar 

  86. Schrader JW, Edelman GM (1976) Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells. J Exp Med 143:601–614

    PubMed  CAS  Google Scholar 

  87. Seibert E, Sorg C, Happle R, Macher E (1976) Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells. Int J Cancer 19:172–178

    Google Scholar 

  88. Shackelford DA, Kaufman JF, Korman AJ, Strominger JL (1982) H LADR antigens: structure, separation of subpopulations, gene cloning and function. Immunol Rev 66:133–187

    PubMed  CAS  Google Scholar 

  89. Sober AJ, Day CL Jr, Fitzpatrick TB, Lew RA, Kopf AW, Mihm MC Jr (1983) Early death from clinical stage I melanoma. J Invest Dermatol 80:050–052

    Google Scholar 

  90. Sober AJ, Day CL, Fitzpatrick TB, Lew RA, Kopf AW, Mihm MC Jr (1983) Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage 1 patients. J Invest Dermatol 80:053–055

    Google Scholar 

  91. Sorg C, Geczy CL (1978) Antibodies to guinea pig lymphokines. VII reactivity with products of lymphoid and nonlymphoid cells. J Immunol 121:1199–1205

    PubMed  CAS  Google Scholar 

  92. Sorg C, Bröcker EB, Zwadlo G, Redmann K, Feige U, Ax W, Feller AC (1985) A monoclonal antibody to a formaldehyde-resistant epitope on the nonpolymorphic constant parts of the HLA-DR antigens. Transplantation 39:90–93

    PubMed  CAS  Google Scholar 

  93. Stenzinger W, Brüggen J, Macher E, Sorg C (1983) Tumor angiogenic activity (TAA) production in vitro and growth in the nude mouse by human malignant melanoma. Eur J Cancer Clin Oncol 19:649–656

    PubMed  CAS  Google Scholar 

  94. Stingl G, Katz SI, Clement L, Green I, Shevach EM (1978) Immunologic functions of labearing epidermal Langerhans cells. J Immunol 121:2005–2013

    PubMed  CAS  Google Scholar 

  95. Suter L, Bröcker EB, Brüggen J, Ruiter DJ, Sorg C (1983) Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies. Cancer Immunol Immunother 16:53–58

    PubMed  CAS  Google Scholar 

  96. Thompson PG (1973) Relationship of lymphocytic infiltration to prognosis in primary malignant melanoma of skin. Pigment Cell 1:285–291

    Google Scholar 

  97. Thorsby E, Bergholtz B, Berle E, Braathen L, Hirschberg H (1981) Involvement of HLA in T-cell immune responses. Transplant Proc 13:903–908

    PubMed  CAS  Google Scholar 

  98. Tötterman TH, Häyry P, Saksela E, Timonen T, Eklund B (1978) Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. II. Functional investigations of the infiltrating inflammatory cells. Eur J Immunol 81:872–875

    Google Scholar 

  99. Trau H, Rigel DS, Harris MN, Kopf AW, Friedman RJ, Gumport SL, Bart RS, Grier WRN (1983) Metastases of thin melanomas. Cancer 51:553–556

    PubMed  CAS  Google Scholar 

  100. Treves AJ, Carnaud C, Trainin N, Feldman M, Cohen IR (1974) Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. Eur J Immunol 4:722–727

    PubMed  CAS  Google Scholar 

  101. Tritsch H (1972) Untersuchungen über Relationen zwischen entzündlicher Infiltration, Zelltyp und Prognose beim malignen Melanom. Arch Dermatol Forsch 244:222–224

    PubMed  CAS  Google Scholar 

  102. van der Esch EP, Cascinelli N, Preda F, Morabito A, Bufalino R (1981) Stage 1 melanoma of the skin: evaluation of prognosis according to histologic characteristics. Cancer 48:1668–1673

    Google Scholar 

  103. van Duinen SG, Ruiter DJ, Bröcker EB, Sorg C, Welvaart K, Ferrone S (1984) Association of low level of HLA-A, B, C, antigens or high level of la antigens in metastatic melanoma with a high grade of malignancy. J Invest Dermatol 82:558

    Google Scholar 

  104. van Duinen SG, Ruiter DJ, Hageman P, Vennegoor C, Dickersin GR, Scheffer E, Rümke P (1984) Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma with a high grade of malignancy. Cancer 53:1566–1573

    PubMed  Google Scholar 

  105. Verbi W, Greaves MF, Schneider C, Koubek K, Kanossy G, Stein H, Kung P, Goldstein G (1982) Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte “receptors”. Eur J Immunol 12:81–86

    PubMed  CAS  Google Scholar 

  106. Veronesi U, Adamus J, Aubert C, Bajetta E, Beretta G, Bonadonna G, Bufalino R, Cascinelli N, Cocconi G, Durand J, De Marsillac J, Ikonopisov RL, Kiss B, Lejeune F, MacKie R, Madej G, Mulder H, Mechl Z, Milton GW, Morabito A, Peter H, Priario J, Paul E, Rumke P, Sertoli R, Tomin R (1982) A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med 307:913–916

    PubMed  CAS  Google Scholar 

  107. Vose M, Moore M (1979) Suppressor cells activity of lymphocytes infiltrating human lung and breast tumours. Int J Cancer 24:579–585

    CAS  Google Scholar 

  108. Vose BM, Bonnard GD (1982) Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2. Int J Cancer 29:33–39

    PubMed  CAS  Google Scholar 

  109. Vose BM (1982) Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: Limiting dilution analysis in peripheral blood and at the tumour site. Int J Cancer 30:135–142

    PubMed  CAS  Google Scholar 

  110. Vose BM, Ferguson R, Moore M (1982) Mitogen responsiveness and inhibitory activity of mesenteric lymph node cells. Cancer Immunol Immunother 13:105–111

    PubMed  CAS  Google Scholar 

  111. Weidner F, Hornstein OP (1983) Untersuchungen zur prognostischen Bedeutung der „Stromareaktion” beim malignen Melanom. II. Entzündliches Infiltrat und Prognose. Virchows Arch [A] 359:77–85

    Google Scholar 

  112. Weitberg AB, Weitzman SA, Destrempes M, Latt SA, Stossel TP (1983) Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N Engl J Med 308:26–30

    PubMed  CAS  Google Scholar 

  113. Whitwell HL, Hughes HPA, Moore M, Ahmed A (1984) Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease. Br J Cancer 49:161–172

    PubMed  CAS  Google Scholar 

  114. Wilson BS, Herzig MA, Lloyd RC (1984) Immunoperoxidase staining for la-like antigens in paraffin-embedded tissues from human melanoma and lung carcinoma. Am J Pathol 115:102–116

    PubMed  CAS  Google Scholar 

  115. Zwadlo G, Bröcker EB, von Bassewitz DB, Feige U, Sorg C (1985) A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 134:1487–1492

    PubMed  CAS  Google Scholar 

Nachtrag

  1. Macher E, Kleeberg UR, Lejeune F, Rümke Ph, Prade M, Thomas D, Suciu S (1986) A randomized phase-III-study on DTIC, Levamisole, and placebo as adjuvant treatment of high risk stage I primary melanoma. J Cancer Res Clin Oncol 111:147

    Google Scholar 

  2. Luger TA, Köck A, Danner M, Vetterlein M, Kudlacek S, Micksche M (1986) Production of distinct cytokines by human melanoma cells. J Invest Dermatol 86:338

    Google Scholar 

  3. Hersey P, Murray E, Grace J, McCarthy WH (1985) Current research on immunôpathology of melanoma: analysis of lymphocyte population in relation to antigen expression and histological features of melanoma. Pathology 17:385–391

    PubMed  CAS  Google Scholar 

  4. Bröcker EB, Zwadlo G, Sorg C (1986) Changes in the inflammatory infiltrates of cutaneous melanoma in the course of tumor progression. J Invest Dermatol, in press (Abstract)

    Google Scholar 

  5. Carrel S, Schmidt-Kessen A, Giuffrè L (1985) Recombinant interferon-y can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens. Eur J Immunol 15:118–123

    PubMed  CAS  Google Scholar 

  6. Dippold WG, Knuth A, Meyer zum Büschenfelde KH (1985) Inflammatory tumor response to monoclonal antibody infusion. Eur J Cancer Clin Oncol 21:907–912

    PubMed  CAS  Google Scholar 

  7. Bröcker EB Suter L Brüggen J, Ruiter DJ, Macher E, Sorg C (1985) Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer 36:29–35

    PubMed  Google Scholar 

Download references

Authors
  1. E.-B. Bröcker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Brüggen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Suter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Sorg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Macher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hämatologisch-Onkologische Praxis Altona, Max-Brauer-Allee 52, D-2000, Hamburg 50, Deutschland

    Holger Voigt  & Ulrich R. Kleeberg  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bröcker, EB., Brüggen, J., Suter, L., Sorg, C., Macher, E. (1986). Immunologische Aspekte maligner Melanome. In: Voigt, H., Kleeberg, U.R. (eds) Malignes Melanom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70460-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70460-4_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70461-1

  • Online ISBN: 978-3-642-70460-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation